137 related articles for article (PubMed ID: 10817846)
1. Beta-blockers - again, a lesson to us all, especially the research funding community.
Coats AJ
Int J Cardiol; 2000 Apr; 73(2):103-4. PubMed ID: 10817846
[No Abstract] [Full Text] [Related]
2. Heart failure: A case for subspecialized care management.
Smith JJ; Konstam MA
Am Heart J; 1999 Jul; 138(1 Pt 1):14-6. PubMed ID: 10385756
[No Abstract] [Full Text] [Related]
3. [Treatment of heart failure based on large-scale clinical trials: renin-angiotensin system antagonists and beta-blockers].
Kubota T; Takeshita A
Nihon Rinsho; 2003 May; 61(5):801-6. PubMed ID: 12755006
[TBL] [Abstract][Full Text] [Related]
4. [Combination therapy of beta blockers for heart failure].
Watanabe M; Hirata Y
Nihon Rinsho; 2007 May; 65 Suppl 5():129-33. PubMed ID: 17571376
[No Abstract] [Full Text] [Related]
5. Angiotensin-converting enzyme inhibitors or beta-blockers in heart failure: does it matter who goes first?
Fang JC
Circulation; 2005 Oct; 112(16):2380-2. PubMed ID: 16230494
[No Abstract] [Full Text] [Related]
6. [Combination therapy with ARB for heart failure].
Sakata Y
Nihon Rinsho; 2007 May; 65 Suppl 5():123-7. PubMed ID: 17569310
[No Abstract] [Full Text] [Related]
7. [AT1 blockers against heart failure. The charm of polypharmacy].
MMW Fortschr Med; 2003 Sep; 145(38):6. PubMed ID: 14603670
[No Abstract] [Full Text] [Related]
8. AstraZeneca's investment in landmark trials in heart failure.
Cardiovasc J S Afr; 2002; 13(1):38-40. PubMed ID: 11998800
[No Abstract] [Full Text] [Related]
9. Current guidelines in the management of chronic heart failure: practical issues in their application to the community population.
McDonald K
Eur J Heart Fail; 2005 Mar; 7(3):317-21. PubMed ID: 15718171
[No Abstract] [Full Text] [Related]
10. The effects of angiotensin receptor antagonists on mortality and morbidity in heart failure--and an interaction with beta blockade.
Coats AJ
Int J Cardiol; 2001 Jan; 77(1):1-4. PubMed ID: 11150619
[No Abstract] [Full Text] [Related]
11. [Administration of beta blockers for chronic heart failure].
Walma EP
Ned Tijdschr Geneeskd; 2000 Nov; 144(48):2325-6. PubMed ID: 11143301
[No Abstract] [Full Text] [Related]
12. Angiotensin-converting enzyme inhibitors, beta-blockers, and mortality in systolic heart failure.
Thornton PL; Ahmed A
J Am Coll Cardiol; 2004 Apr; 43(7):1333; author reply 1333-4. PubMed ID: 15063454
[No Abstract] [Full Text] [Related]
13. [Antiarrhythmic drug therapy in patients with heart failure].
Nakamura K; Nishii N; Ohe T
Nihon Rinsho; 2007 May; 65 Suppl 5():369-74. PubMed ID: 17571408
[No Abstract] [Full Text] [Related]
14. Are Angiotensin-converting enzyme inhibitors and beta-blockers ineffective in children with dilated cardiomyopathy and heart failure?
Singh TP; Almond C
J Am Coll Cardiol; 2010 Aug; 56(10):823; author reply 823-4. PubMed ID: 20797500
[No Abstract] [Full Text] [Related]
15. Could beta-blockers precede or replace angiotensin-converting enzyme inhibitors in heart failure?
Remme WJ
Heart Fail Clin; 2005 Apr; 1(1):67-75. PubMed ID: 17386835
[No Abstract] [Full Text] [Related]
16. [Risk reduction of acute heart failure with initial administration of beta-blockers].
Med Monatsschr Pharm; 2007 Apr; 30(4):158. PubMed ID: 17484449
[No Abstract] [Full Text] [Related]
17. Interaction of beta-blockers and angiotensin receptor blockers/ACE inhibitors in heart failure.
Cohn JN
J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):137-9. PubMed ID: 14608516
[TBL] [Abstract][Full Text] [Related]
18. Clinical trials of beta-blockers in heart failure: a class review.
Yancy CW
Am J Med; 2001 Apr; 110 Suppl 5A():7S-10S. PubMed ID: 11259751
[TBL] [Abstract][Full Text] [Related]
19. Lack of deleterious interaction between angiotensin receptor blockers and beta-blockers in the treatment of patients with heart failure.
Hennekens CH; Kowalczykowski M; Hollar D
J Cardiovasc Pharmacol Ther; 2006 Jun; 11(2):149-52. PubMed ID: 16891293
[TBL] [Abstract][Full Text] [Related]
20. The kidney in congestive heart failure: renal adverse event rate of treatment.
Delles C; Schmieder RE
J Cardiovasc Pharmacol; 2001 Jul; 38(1):99-107. PubMed ID: 11444507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
